<DOC>
	<DOCNO>NCT00963989</DOCNO>
	<brief_summary>The primary objective clinical evaluation determine safety effectiveness Penumbra System stroke cohort present within 8 hour symptom know core infarct volume admission . The secondary objective determine correlation infarct volume functional outcome treat patient 90 day post-procedure .</brief_summary>
	<brief_title>Imaging Guided Patient Selection Interventional Revascularization Therapy</brief_title>
	<detailed_description>Study Title : The START Trial : Clinical Outcome Acute Stroke Treatment Imaging Guided Patient Selection Interventional Revascularization Therapy Study Objective : The objective clinical evaluation determine safety effectiveness Penumbra System stroke cohort present within 8 hour symptom onset know core infarct volume admission . The data also use determine correlation infarct volume functional outcome 90 day post-procedure . Safety define procedural serious adverse event , effectiveness define rate revascularization ( TIMI 2-3/TICI 2a-3 ) good functional outcome . Good functional outcome define modified Rankin scale ( mRS ) score 2 less 90 day post-procedure . Core infarct volume admission assess compute tomography perfusion ( CTP ) , compute tomography angiography ( CTA ) magnetic resonance DWI scan . The core infarct volume sub-grouped &lt; 50cc , 50-100cc &gt; 100cc determine correlation patient functional outcome . Study Design : A prospective , single arm , multi-center trial . Up 200 patient 45 center enrol study . It anticipate 150 evaluable patient need analysis . Patient Population : Patients present symptom acute ischemic stroke within 8 hour symptom onset know imaging-defined infarct volume enrol interventional treatment Penumbra System achieve revascularization target vessel territory . Indication : The Penumbra System intend use revascularization patient acute ischemic stroke secondary intracranial large vessel occlusive disease ( within internal carotid , middle cerebral - M1 M2 segment , basilar , vertebral artery ) within 8 hour symptom onset . Sample Size Justification : Up 200 subject enrol order obtain 150 evaluable patient . Assuming post-procedure angiographic success ( TIMI 2-3/TICI 2a-3 ) rate 80 % ( 120/150 ) , expect two-sided exact binomial 95 % confidence interval ( 72.7 % , 86.1 % ) . Assuming 90-day mRS success ( mRS 0-2 ) rate 30 % , expect two-sided exact binomial 95 % confidence interval ( 22.8 % , 38.0 % ) . Additionally , study result use sample size estimate potential future randomize , concurrent control trial . Core Laboratory Clinical Event Committee An independent Core Lab review score image scan infarct volume , TIMI , TICI ICH . A Clinical Event Committee adjudicate Serious Adverse Events severity causality ( disease- , procedure- , drug- , device-relatedness . Study Rationale : Use interventional revascularization technique offer several potential clinical benefit improve cerebral perfusion target vascular territory certain patient . The validation simple , pragmatic , executable image guide patient selection paradigm may identify cohort acute stroke patient benefit interventional treatment Penumbra System revascularization treatment acute stroke indicate .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>From 18 85 year age . Evidence proximal anterior circulation large vessel occlusion ( TIMI /TICI 01 ) ( Tables 2A &amp; B ) . Target vessel occlusion may include supraclinoid segment ICA M1 segment MCA . Presented symptoms consistent acute ischemic stroke within 8 hour symptom onset . Patients present within 3 hour must ineligible refractory IV rtPA therapy . At time enrollment , neurological deficit result NIH Stroke Scale ( NIHSS ) score 10 great . Core infarct volume assess CTP , CTA DWI scan within 60 minute arterial puncture . Signed informed consent . History stroke past 3 month . Vessel tortuosity difficult allow endovascular access . Preexisting neurological psychiatric disease could confound study result prestroke mRS score 1 great . Known severe allergy contrast medium . Uncontrolled hypertension ( define systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg ) . Noncontrast CT evidence follow condition enrollment : Significant mass effect midline shift ; Evidence intracranial hemorrhage . Angiographic evidence arterial stenosis proximal occlusion could prevent thrombus removal . Angiographic evidence preexist arterial injury . Life expectancy le 90 day . Participation another clinical investigation could confound evaluation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Acute stroke</keyword>
	<keyword>Large cerebral vessel occlusion</keyword>
	<keyword>Core infarct volume</keyword>
	<keyword>Penumbra System</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Intracerebral hemorrhage</keyword>
	<keyword>mRS</keyword>
	<keyword>NIHSS</keyword>
	<keyword>Procedural serious adverse event</keyword>
	<keyword>All cause mortality</keyword>
</DOC>